A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

Clicks: 536
ID: 112421
1987
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 27 articles by views in Journal of the American College of Cardiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A model was designed to examine the relations between incremental costs and benefits of coronary thrombolysis/reperfusion therapy. The model allows for the study of intravenous and intracoronary streptokinase, intravenous tissue plasminogen activator and primary angioplasty. Three strategies for the …
Reference Key
gl1987journala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Laffel GL;Fineberg HV;Braunwald E;;
Journal Journal of the American College of Cardiology
Year 1987
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/2959718
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine models Recurrence risk factors time factors decision trees theoretical* cost-benefit analysis pmid:2959718 doi:10.1016/s0735-1097(87)80432-1 g l laffel h v fineberg e braunwald angioplasty balloon / economics* coronary angiography coronary disease / economics* coronary thrombosis / economics* coronary thrombosis / mortality coronary thrombosis / therapy coronary vessels* drug evaluation myocardial infarction / economics myocardial infarction / mortality myocardial infarction / therapy stroke volume / drug effects willingness to pay myocardium intravenous primary angioplasty thrombolysis/reperfusion therapy reocclusion coronary occlusion

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.